Send to

Choose Destination
J Pediatr. 1992 Mar;120(3):479-83.

Pharmacokinetics of lorazepam in critically ill neonates with seizures.

Author information

Department of Pediatrics, Lutheran General Children's Medical Center, Park Ridge, Illinois.


Pharmacokinetic data were evaluated in 10 term neonates with seizures after intravenous administration of lorazepam, 0.05 mg/kg or 0.1 mg/kg. All seizure activity ceased, with no adverse effects. Pharmacokinetic data revealed a decreased volume of distribution and clearance, and a prolonged half-life in comparison with data from older children and adults. These findings are consistent with physiologic differences in the neonate.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center